CClinicalTrials.gg
CompletedNCT02685722UC-MSCsUpdated Feb 19, 2016

UC-MSCs Gel Treatment Difficult Healing of Skin Ulcers

A Phase 1 interventional study of UC-MSCs Gel group and Gel group in Difficult to Healing of Skin Ulcers, sponsored by Chinese PLA General Hospital. Completed at 1 site in China. Open to participants aged 17 Years to 78 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-02-19.

Sponsored by Chinese PLA General Hospital · Phase 1, Interventional, and Treatment

Phase
Phase 1
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
17 Years to 78 Years
Sex
All
01

Study summary

This study for a six-month trials, Randomized, open, and parallel comparison before and after its own, Stage test includes screening stage, treatment period and follow-up period. In accordance with chronic wound criteria for the patient, By producing the principle of random number, Were randomly divided into UC-MSCs Gel group or Gel group, The researchers according to the situation of wound healing time and decided to use the secondary treatment, To observe the clinical efficacy and safety.

02

Conditions studied

  • Difficult to Healing of Skin Ulcers

Browse trials for

03

In context

Skin Ulcer

79 studies on the registry are indexed under Skin Ulcer; 14 are open to participants now.

This study's enrollment of 20 is below the median of 44 across 65 interventional studies indexed under Skin Ulcer.

Browse Skin Ulcer studies →

Lead sponsor

Chinese PLA General Hospital is the lead sponsor of 558 studies on the registry; 202 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
17 Years to 78 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Older than 17 year old male or female (pregnancy);
  • Has the ability to care for, has the ability to self signed informed consent, 7 to 17 years of age must be signed by the guardian informed consent;
  • The process of psychological stability, can finish the tes

Exclusion criteria

Exclusion Criteria:

  • Allergic constitution, or known allergic to pork or beef source products, gao min physique person;
  • The wound is more than 10 cm by 10 cm;
  • People with mental illness, drug abusers and or other items;
  • 1 month used or are using the sugar metabolism of drugs, such as corticosteroids, thiazide diuretics, tricyclic antidepressants, etc;
  • 3 month participated in other similar test;
  • Serious infectious disease not controller;
  • With surgery, such as severe trauma stress situation;
  • Always had a history of tumor;
  • Clinical researchers or for other reasons can't cooperate with the doctors, and other information is not suitable for clinical study of patients.
05

Study design

Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
20 participants (actual)

Study arms

  • Experimental
    UC-MSCs Gel group

    This study for a six-month trials,Randomized, open, and parallel comparison before and after its own,Stage test includes screening stage, stochastic screening of more than a month difficult to heal wounds 20 people.treatment period and follow-up period.In accordance with chronic wound criteria for the patient,By producing the principle of random number,Were randomly divided into UC-MSCs Gel group or Gel group,The researchers according to the situation of wound healing time and decided to use the secondary treatment,to observe the clinical efficacy and safety.

    Biological: UC-MSCs Gel group

  • Experimental
    Gel group

    This study for a six-month trials,Randomized, open, and parallel comparison before and after its own,Stage test includes screening stage, stochastic screening of more than a month difficult to heal wounds 20 people.treatment period and follow-up period.In accordance with chronic wound criteria for the patient,By producing the principle of random number,Were randomly divided into UC-MSCs Gel group or Gel group,The researchers according to the situation of wound healing time and decided to use the secondary treatment,to observe the clinical efficacy and safety.

    Other: Gel group

Interventions

  • BiologicalUC-MSCs Gel group

    This study for a six-month trials,Randomized, open, and parallel comparison before and after its own,Stage test includes screening stage, stochastic screening of more than a month difficult to heal wounds 20 people.By generating a random number of principle,Observation of UC-MSCs Gel group patients efficacy, safety and tolerability of selective parameter.

  • OtherGel group

    This study for a six-month trials,Randomized, open, and parallel comparison before and after its own,Stage test includes screening stage, stochastic screening of more than a month difficult to heal wounds 20 people.By generating a random number of principle,observed and compared Gel group patients may be no efficacy.

06

What researchers measure

Primary outcomes

  1. Frequency of Adverse Events

    Frequency and severity of Adverse Events

    Time frame: 6 months

Secondary outcomes

  1. Relative Wound Area Regression of 40% or More at 6 Week

    Time frame: 6 week

07

Study locations

1 site
  • Chinese PLA General Hospital
    Beijing, 100039, China
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 19, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02685722
Lead sponsor
Chinese PLA General Hospital
Responsible party
Xiaobing Fu (Principal Investigator, Chinese PLA General Hospital) — Principal investigator
First posted
Feb 19, 2016
Start date
Jan 2012
Primary completion
Dec 2015
Completion
Dec 2015
Last update
Feb 19, 2016

Study contacts

xiaobing Fu
principal investigator · Chinese PLA General Hospital

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion